PROTAC BRD9-binding moiety 5
PROTAC BRD9-binding moiety 5 is a selective BRD9 binder with an IC50 value of 4.20 μM, can be used for the synthesis of PROTACs. PROTAC BRD9-binding moiety 5 has antiproliferative activity against cancer cells[1].
Product Specifications
CAS Number
893633-37-9
UNSPSC
12352005
Target
Epigenetic Reader Domain; Ligands for Target Protein for PROTAC
Type
Reference compound
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protac-brd9-binding-moiety-5.html
Solubility
10 mM in DMSO
Smiles
CCC1=NN=C2C(NC3=CC(NC(C)=O)=CC=C3)=NC4=C(N12)C=CC=C4
Molecular Formula
C19H18N6O
Molecular Weight
346.39
References & Citations
[1]Pierri M, et al. Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders. Bioorg Chem. 2022 Jan;118:105480.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD9
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7198466 Inquire
Rabbit anti-Escherichia coli O157:H7 ugd Polyclonal Antibody
Sign In for Pricing
View Details 
bs-7774R-Biotin 100 µL
Septin 3 Polyclonal Antibody, Biotin Conjugated
Sign In for Pricing
View Details 
